Gracell Biotechn Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TEMASEK HOLDINGS (PRIVATE) LTD | 02/14/2024 | 9.59 M | $96.27 M | -3.16% | 11.43% |
| VIVO CAPITAL, LLC | 02/07/2024 | 9.55 M | $95.85 M | -12.27% | 11.38% |
| ORBIMED ADVISORS LLC | 02/14/2024 | 9.31 M | $93.46 M | 0.00% | 11.09% |
| SIO CAPITAL MANAGEMENT, LLC | 02/13/2024 | 5.00 M | $50.22 M | 140.32% | 5.96% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2024 | 4.51 M | $45.33 M | 48.57% | 5.38% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2024 | 2.19 M | $22.00 M | 1,277.50% | 2.61% |
| BAKER BROS. ADVISORS LP | 02/14/2024 | 2.08 M | $20.88 M | 108.00% | 2.48% |
| PENTWATER CAPITAL MANAGEMENT LP | 02/14/2024 | 1.46 M | $14.67 M | 100.00% | 1.74% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2024 | 1.38 M | $13.81 M | 0.00% | 1.64% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2024 | 1.35 M | $13.55 M | 58.82% | 1.61% |
| TIG ADVISORS, LLC | 02/14/2024 | 1.28 M | $12.85 M | 100.00% | 1.52% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 02/12/2024 | 1.28 M | $12.84 M | 100.00% | 1.52% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2024 | 596.61 K | $5.99 M | 100.00% | 0.71% |
| BLACKROCK INC. | 02/13/2024 | 539.97 K | $5.42 M | -3.48% | 0.64% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/13/2024 | 517.27 K | $5.19 M | 19,590.67% | 0.62% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 511.95 K | $5.14 M | 76,885.41% | 0.61% |
| LMR PARTNERS LLP | 02/14/2024 | 510.00 K | $3.31 M | 5.26% | 0.61% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/15/2024 | 502.94 K | $5.05 M | -67.16% | 0.60% |
| MMCAP INTERNATIONAL INC. SPC | 02/12/2024 | 451.17 K | $4.53 M | 100.00% | 0.54% |
| HARVEST MANAGEMENT LLC | 02/14/2024 | 400.00 K | $4.02 M | 100.00% | 0.48% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2024 | 266.67 K | $2.68 M | -86.67% | 0.32% |
| MARSHALL WACE, LLP | 02/14/2024 | 192.47 K | $1.93 M | 61.07% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 191.27 K | $1.92 M | 1,105.91% | 0.23% |
| AQR ARBITRAGE LLC | 02/14/2024 | 130.78 K | $1.31 M | 100.00% | 0.16% |
| UBS GROUP AG | 02/09/2024 | 125.68 K | $1.26 M | 5,336.03% | 0.15% |
| WEISS ASSET MANAGEMENT LP | 02/12/2024 | 109.40 K | $1.10 M | 100.00% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 87.60 K | $879.48 K | 167.04% | 0.10% |
| MORGAN STANLEY | 08/16/2024 | 78.12 K | $784.32 K | -20.81% | 0.09% |
| CSS LLC/IL | 02/14/2024 | 73.00 K | $732.92 K | 100.00% | 0.09% |
| INVESCO LTD. | 02/13/2024 | 62.86 K | $631.15 K | -3.47% | 0.07% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2024 | 59.06 K | $592.99 K | 4,097.80% | 0.07% |
| FIFTH LANE CAPITAL, LP | 02/14/2024 | 58.34 K | $585.69 K | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 02/14/2024 | 57.80 K | $580.32 K | 100.00% | 0.07% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/14/2024 | 50.00 K | $502.00 K | 100.00% | 0.06% |
| JBF CAPITAL, INC. | 02/13/2024 | 50.00 K | $502.00 K | 100.00% | 0.06% |
| PATHSTONE HOLDINGS, LLC | 02/14/2024 | 49.16 K | $493.55 K | 100.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 43.33 K | $435.07 K | 0.00% | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2024 | 40.97 K | $411.38 K | 150.96% | 0.05% |
| EXOME ASSET MANAGEMENT LLC | 02/15/2024 | 40.97 K | $411.38 K | 100.00% | 0.05% |
| GABELLI FUNDS LLC | 02/13/2024 | 39.85 K | $400.09 K | 100.00% | 0.05% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 39.30 K | $395.00 K | -15.67% | 0.05% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 02/13/2024 | 34.30 K | $344.37 K | 100.00% | 0.04% |
| TWO SIGMA ADVISERS, LP | 02/14/2024 | 33.60 K | $337.34 K | 100.00% | 0.04% |
| GTS SECURITIES LLC | 02/15/2024 | 25.14 K | $252.45 K | 100.00% | 0.03% |
| ROYAL BANK OF CANADA | 02/14/2024 | 25.03 K | $251.00 K | 100.00% | 0.03% |
| OASIS MANAGEMENT CO LTD. | 02/14/2024 | 25.00 K | $251.00 K | 100.00% | 0.03% |
| EQUITEC PROPRIETARY MARKETS, LLC | 01/29/2024 | 23.70 K | $237.95 K | 100.00% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 22.60 K | $226.90 K | 100.00% | 0.03% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 02/14/2024 | 22.57 K | $300.26 K | 100.00% | 0.03% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 02/13/2024 | 21.92 K | $220.12 K | 100.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gracell Biotechn institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Gracell Biotechn. The most heavily invested institutionals were:
PATHSTONE FAMILY OFFICE, LLC: 49,158
Brainard Capital Management LLC: 25,913
Marshall Wace North America L.P.: 82,348
65.72% of Gracell Biotechn stock is owned by institutional investors.
Institutional investors have bought a total of 157.42 K shares in the last 24 months. This purchase volume represents approximately $1.61 M in transactions.